...
首页> 外文期刊>Cell death & disease. >Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc
【24h】

Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc

机译:P66SHC趋化因子受体信号和B细胞趋化性的负调节

获取原文
           

摘要

Shc (Src homology 2 domain containing) adaptors are ubiquitous components of the signaling pathways triggered by tyrosine kinase-coupled receptors. In lymphocytes, similar to other cell types, the p52 and p66 isoforms of ShcA/Shc participate in a self-limiting loop where p52Shc acts as a positive regulator of antigen receptor signaling by promoting Ras activation, whereas p66Shc limits this activity by competitively inhibiting p52Shc. Based on the fact that many signaling mediators are shared by antigen and chemokine receptors, including p52Shc, we have assessed the potential implication of p66Shc in the regulation of B-cell responses to chemokines, focusing on the homing receptors CXCR4 (C-X-C chemokine receptor type 4) and CXCR5 (C-X-C chemokine receptor type 5). The results identify p66Shc as a negative regulator of the chemotactic responses triggered by these receptors, including adhesion, polarization and migration. We also provide evidence that this function is dependent on the ability of p66Shc to interact with the chemokine receptors and promote the assembly of an inhibitory complex, which includes the phosphatases SHP-1 (Src homology phosphatase-1) and SHIP-1 (SH2 domain-containing inositol 5'-phosphatase-1), that results in impaired Vav-dependent reorganization of the actin cytoskeleton. This function maps to the phosphorylatable tyrosine residues in the collagen homology 1 (CH1) domain. The results identify p66Shc as a negative regulator of B-cell chemotaxis and suggest a role for this adaptor in the control of B-cell homing.
机译:SHC(SRC同源性2结构域)适配器是由酪氨酸激酶偶联受体触发的信号传导途径的无处不在的组分。在淋巴细胞中,类似于其他细胞类型,SHCA / SHC的P52和P66同种型参与自限流环,其中P52SHC通过促进RAS活化作为抗原受体信号传导的正调节剂,而P66SHC通过竞争性地抑制P52SHC限制该活动。基于许多信号调解器由抗原和趋化因子受体共享,包括P52SHC,我们评估了P66SHC在对趋化因子的调节中的潜在意义,重点是归巢受体CXCR4(CXC趋化因子型4 )和CXCR5(CXC趋化因子受体类型5)。结果鉴定P66SHC作为由这些受体引发的趋化反应的负调节剂,包括粘附,极化和迁移。我们还提供了证据,即该功能取决于P66SHC与趋化因子受体相互作用的能力,并促进抑制络合物的组装,其包括磷酸酶SHP-1(SRC同源性磷酸酶-1)和船-1(SH2结构域 - 占肌醇5'-磷酸酶-1),导致肌动蛋白细胞骨架的VAV依赖性重组受损。该功能映射到胶原同源1(CH1)结构域中的可磷酸化酪氨酸残基。结果鉴定P66SHC作为B细胞趋化性的负调节剂,并表明该适配器在B细胞归巢中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号